European Patent Office

The claim also covers viewers in 19 European countries served through a Frankfurt-based server location.

The EPO's Enlarged Board of Appeal ruled on September 3rd, in G1 of 25, that the patent description only needs to be amended to match amended claims.

if a discrepancy between the two, the claims in the description, causes a requirement of the EPC, such as clarity, novelty, inventive step, not to be met.

The EPO's Board of Appeal fully revoked Moderna's key mRNA patent EP3590949 following a two-day hearing that concluded in mid-September 2026, on the grounds that the claimed subject matter extended beyond the original application.

The revocation removes the basis for Moderna's earlier wins against BioNTech and Pfizer in Dusseldorf in London.

On September 15th, US sportswear maker New Balance filed a trademark infringement suit against Decathlon's US units, in the US District Court for the District of Massachusetts.

And there we see offensive litigation as a good choice.

And that is Germany, US and China.

For example, Stephanie gained industry experience with the leading technology company of measurement and high-frequency technology in the field of measurement technology for LTE.

Working with a variety of clients from all over the world, Stephanie specializes in prosecution and oppositions at the European Patent Office and German Patent Office, freedom to operate, and patent drafting, in particular in the fields of computer-implemented inventions.

Daphne studied electrical engineering at the Technical University of Munich.

She wrote her master thesis at the Chair of Communication Networks in the field of artificial intelligence with a focus on reinforcement learning.

He explained how their documentation from plant variety rights applications is useful to our patent examiners here at the

EPO.

The CPVO is providing some technical documentation to the EPO, which are inserted into the database that the examiners are using for their daily work.

I think it's really an added value for the quality of the patent granted by the EPO that we could have access to this documentation.

For most technical inventions, solar panels, telephones, jet engines, there is no argument about them being novel, inventive and useful.

But when we get into the area of plant biotechnology, it's not that simple.

And it's essentially biological when there's a breeding step, when basically two organisms come together and where there's a natural step of sexual reproduction.

Then it's considered an essentially biological process and then it's not patentable.

We've got, but what's, Your audience, what the people want to know is, does it work? Does it make my liver younger? Does it make my dog younger? And right now, we can have that.

They want to know, do you have a patent that protects your business? We are now expecting the European Patent Office to within the next four months.

So it's all coming together.

The company matured a lot.

It's moving forward in the U.S. under accelerated.

The most upcoming is in Europe and there has been delayed.

We received a letter from the European Patent Office saying they experienced a little bit of delay.

We were expecting to have this patent granted in June.

And through them, you know, I got to, I got exposed to All the Erasmus Plus programs that they do, I really got to engage with young people from various different aspects, technical, political, sociological, and that I really feel like is what gives the bioeconomy its strength outside of the technical perspectives.

So now you're living and working in the Netherlands at the European Patent Office.

So how has this shifted your perspective of the bioeconomy? Of course, when I'm asking, I'm asking for your perspective, not for the organization, but I'm sure that working hands-on does change the way you see some things, perhaps.

So how does it change the way you view bioeconomy?

But being essentially a little bit of a tourist, a little bit of something like innovation is something that's dear to me, but I'm learning this from first principles.

But you really get a perspective that nobody else gets.

It really shows how committed the European Patent Office is to enabling systemic change through innovation.

It's really cool.